Previous research indicates that drug use is common among incarcerated populations. However, much less research attention has been focused on drug use among female inmates, especially while in prison. The goal of this research was to examine the prevalence and correlates of in-prison drug use among women prisoners. Data were drawn from a random sample of women incarcerated in four regions of Spain in 2014. Self-report assessments of alcohol and drug use were collected. Descriptive analyses and logistic regression models were employed to examine relationships in the data. Overall, the results revealed a high prevalence of substance use while in prison. More than half of study participants (52%) reported using drugs in prison within the past 6 months, with alcohol (33.8%) and cannabis (28.2%) the most commonly reported drugs used. Logistic regression models indicated that age and prior drug use history were significantly associated with in-prison substance use. Notably, criminal history was not a significant predictor of in-prison substance use. Our findings suggest that substance use while in prison may represent a barrier to these women's rehabilitative goals. Study findings are discussed in terms of developing effective drug treatment programs for women prisoners in the Spanish Prison System.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15332640.2016.1255579 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Falling racial inequality and rising educational inequality in US prison admissions for drug, violent, and property crimes.
Proc Natl Acad Sci U S A
January 2025
Department of Sociology and Criminology, Butler University, Indianapolis, IN 46208.
Using administrative and survey data, we show that there has been a sea change in the contours of American imprisonment. At the end of the twentieth century, inequality in the prison admission rates of Black and White Americans was comparable to inequality in the prison admission rates of people with and without a college education. However, educational inequality is now much greater than racial inequality in prison admissions for all major crime types.
View Article and Find Full Text PDFRecent Incarceration and HIV Risk Among Women Who Use Heroin.
JAMA Netw Open
January 2025
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Importance: Women who use heroin in sub-Saharan Africa face elevated HIV risk linked to structural vulnerability including frequent incarceration. However, little is known about the association between incarceration and drug use and HIV outcomes among women who use heroin in Africa.
Objective: To estimate associations between incarceration and adverse HIV-related and drug use-related outcomes among women who used heroin.
Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan.
Neuropsychopharmacol Rep
March 2025
Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Background: Treatment of stimulant offenders in Japan is an urgent issue. One of the more recent support approaches for stimulant offenders in Japan is to understand and support them based on a self-medication hypothesis; however, the effect of trust on substance abuse severity among incarcerated stimulant offenders has not been examined. Additionally, while accounting for gender differences is essential when providing support for them, these differences have not also been examined.
View Article and Find Full Text PDFProgress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection.
Harm Reduct J
December 2024
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Background: People who inject drugs (PWID) are at high risk of blood-borne infections, and injection drug use contributes significantly to hepatitis C virus (HCV) transmission. The WHO has therefore set targets of reducing HCV incidence and prevalence among PWID and increasing treatment coverage to eliminate HCV by 2030. The DRUCK study (2011-2014) found high HCV prevalence and low treatment coverage among PWID in Germany.
View Article and Find Full Text PDFImproving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons.
Lancet Public Health
January 2025
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA; Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA.
The 1990 resolution by the UN General Assembly committed member states to provide health-care equity for people in prison, who are included in the global goals to control HIV and eliminate hepatitis C virus (HCV) by 2030. WHO has set ambitious HCV elimination targets by including people who inject drugs (PWID), yet has not prioritised PWID who are incarcerated, a substantial population who have or are at risk for HCV infection. Human rights principles of health-care equity stipulate that "prisoners should enjoy the same standards of health care that are available in the community, without discrimination on the grounds of their legal status".
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!